Corrigendum: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients

Sci Rep. 2017 Jan 19:7:40272. doi: 10.1038/srep40272.
No abstract available

Publication types

  • Published Erratum